2 minute read

PSYCHEDELIC

opposed Colorado’s ballot measure to decriminalize magic mushrooms, said.

Niforatos points to the risks of other drugs like opioids and cannabis. In MindMed’s LSD trial in Fort Collins, some groups are excluded from participation: pregnant women and people with a history of psychosis.

at’s because the risks of using psychedelics in these populations are not fully understood.

“ at’s not to say that these drugs don’t do what everyone’s really

Constitution,” he said. “I think if it’s OK for the U.S. Constitution, why is it not OK for Colorado’s?”

Nimmo said he has roughly 35 clients who had already led cases under Senate Bill 88 or were hoping to. It’s not clear how many lawsuits had been led under Senate Bill 88 when the Supreme Court issued its ruling, but it’s likely well into the dozens.

Nimmo, said one silver lining is that the Colorado Supreme Court didn’t strike down all of Senate Bill 88. e measure still allows recent and future child sex abuse survivors to overcome the government’s protections from nancial consequences in lawsuits, a right they didn’t have before.

He said while he felt the legal excited about,” Niforatos said. “But what it does mean, though, is it’s still early.” arguments for why Senate Bill 88 was constitutional were strong, he always knew there was a chance a court would disagree. He said lawyers frequently take a chance with their legal interpretations.

Research into a psychedelic called MDMA could be entering its nal phase before possible FDA approval.

Berra Yazar-Klosinski, the chief science o cer with the MAPS Public Bene t Corporation, said MDMA is further along in the process than other psychedelics thanks to a growing body of research on using it to treat mental health issues in conjunction with therapy.

She remembers looking over the results from a phase three clinical trial on using MDMA to treat Post-Traumatic Stress Disorder, published in 2021 in the journal Nature Medicine.

“I never once thought 100% this law was constitutional,” he said. “We thought we had a way to make this complicit with our constitution. We were wrong.” is story is from e Colorado Sun, a journalist-owned news outlet based in Denver and covering the state. For more, and to support e Colorado Sun, visit coloradosun.com. e Colorado Sun is a partner in the Colorado News Conservancy, owner of Colorado Community Media. is KUNC story via e Associated Press’ Storyshare, of which Colorado Community Media is a member.

88% of the participants experienced a meaningful change in their symptoms. Around two-thirds no longer met the criteria for a PTSD diagnosis.

“Oh, my gosh. It was so exciting,” Yazar-Klosinski said of the results.

Later this year, Yazar-Klosinski will be walking the FDA through the data as part of a larger request to approve MDMA-assisted therapy.

“It was such a huge surprise that everybody was just shocked and very happy for the PTSD patients and what this could mean for them,” Yazar-Klosinski said.

This article is from: